83 related articles for article (PubMed ID: 23967071)
1. Indirubin-3'-monoxime exhibits potent antiviral and anti-inflammatory effects against human adenoviruses in vitro and in vivo.
Wang J; Yang C; Liang Z; Sun J; Zhang M; Qiu S; Du X; He X; Pang X; Ma X; Xie M; Han X; Fan R; Zhou E; Yu H; She D; Song H; Wang J
Biomed Pharmacother; 2024 May; 174():116558. PubMed ID: 38603887
[TBL] [Abstract][Full Text] [Related]
2. Transmembrane and Immunoglobulin Domain Containing 1, a Putative Tumor Suppressor, Induces G2/M Cell Cycle Checkpoint Arrest in Colon Cancer Cells.
De La Cena KOC; Ho RX; Amraei R; Woolf N; Tashjian JY; Zhao Q; Richards S; Walker J; Huang J; Chitalia VC; Rahimi N
Am J Pathol; 2021 Jan; 191(1):157-167. PubMed ID: 33129760
[TBL] [Abstract][Full Text] [Related]
3. Blocking Smad2 signalling with loganin attenuates SW10 cell cycle arrest induced by TNF-α.
Chao G; Tian X; Zhang W; Ou X; Cong F; Song T
PLoS One; 2017; 12(5):e0176965. PubMed ID: 28475649
[TBL] [Abstract][Full Text] [Related]
4. Pathogenetic model of survivin-dependent molecular signalling pathways in tumorigenesis of oral cancer and precursor lesions.
Aggarwal D; Shetty DC; Jain A; Gulati N; Juneja S
J Oral Maxillofac Pathol; 2023; 27(2):287-294. PubMed ID: 37854918
[TBL] [Abstract][Full Text] [Related]
5. A Thia-Analogous Indirubin
Wendt F; Wittig F; Rupprecht A; Ramer R; Langer P; Emmert S; Frank M; Hinz B
Cells; 2023 Oct; 12(19):. PubMed ID: 37830623
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effect of plasma-activated medium and novel indirubin derivatives on human skin cancer cells by activation of the AhR pathway.
Rebl H; Sawade M; Hein M; Bergemann C; Wende M; Lalk M; Langer P; Emmert S; Nebe B
Sci Rep; 2022 Feb; 12(1):2528. PubMed ID: 35169210
[TBL] [Abstract][Full Text] [Related]
7. Clocking cancer: the circadian clock as a target in cancer therapy.
Battaglin F; Chan P; Pan Y; Soni S; Qu M; Spiller ER; Castanon S; Roussos Torres ET; Mumenthaler SM; Kay SA; Lenz HJ
Oncogene; 2021 May; 40(18):3187-3200. PubMed ID: 33846572
[TBL] [Abstract][Full Text] [Related]
8. The Role of CDK5 in Tumours and Tumour Microenvironments.
Do PA; Lee CH
Cancers (Basel); 2020 Dec; 13(1):. PubMed ID: 33396266
[TBL] [Abstract][Full Text] [Related]
9. Molecular cloning and metabolomic characterization of the 5-enolpyruvylshikimate-3-phosphate synthase gene from Baphicacanthus cusia.
Yu J; Zhang Y; Ning S; Ye Q; Tan H; Chen R; Bu Q; Zhang R; Gong P; Ma X; Zhang L; Wei D
BMC Plant Biol; 2019 Nov; 19(1):485. PubMed ID: 31706293
[TBL] [Abstract][Full Text] [Related]
10. Effects of indirubin and isatin on cell viability, mutagenicity, genotoxicity and BAX/ERCC1 gene expression.
Fogaça MV; Cândido-Bacani PM; Benicio LM; Zapata LM; Cardoso PF; de Oliveira MT; Calvo TR; Varanda EA; Vilegas W; de Syllos Cólus IM
Pharm Biol; 2017 Dec; 55(1):2005-2014. PubMed ID: 28738722
[TBL] [Abstract][Full Text] [Related]
11. Stable Internal Reference Genes for Normalizing Real-Time Quantitative PCR in
Huang Y; Tan H; Yu J; Chen Y; Guo Z; Wang G; Zhang Q; Chen J; Zhang L; Diao Y
Front Plant Sci; 2017; 8():668. PubMed ID: 28515733
[No Abstract] [Full Text] [Related]
12. Indirubin and Indirubin Derivatives for Counteracting Proliferative Diseases.
Blažević T; Heiss EH; Atanasov AG; Breuss JM; Dirsch VM; Uhrin P
Evid Based Complement Alternat Med; 2015; 2015():654098. PubMed ID: 26457112
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of indirubin-3'-monoxime against human osteosarcoma.
Zhang Y; Song L; Li J; Zhang Y; Lu X; Zhang B
IUBMB Life; 2019 Oct; 71(10):1465-1474. PubMed ID: 31050877
[TBL] [Abstract][Full Text] [Related]
14. Critical role of Bid and Bax in indirubin-3'-monoxime-induced apoptosis in human cancer cells.
Shi J; Shen HM
Biochem Pharmacol; 2008 May; 75(9):1729-42. PubMed ID: 18377873
[TBL] [Abstract][Full Text] [Related]
15. Indirubin-3'-monoxime, a CDK inhibitor induces growth inhibition and apoptosis-independent up-regulation of survivin in transitional cell cancer.
Perabo FG; Frössler C; Landwehrs G; Schmidt DH; von Rücker A; Wirger A; Müller SC
Anticancer Res; 2006; 26(3A):2129-35. PubMed ID: 16827155
[TBL] [Abstract][Full Text] [Related]
16. Monitoring survivin expression in cancer: implications for prognosis and therapy.
Santa Cruz Guindalini R; Mathias Machado MC; Garicochea B
Mol Diagn Ther; 2013 Dec; 17(6):331-42. PubMed ID: 23912862
[TBL] [Abstract][Full Text] [Related]
17. Survivin as a preferential target for cancer therapy.
Mobahat M; Narendran A; Riabowol K
Int J Mol Sci; 2014 Feb; 15(2):2494-516. PubMed ID: 24531137
[TBL] [Abstract][Full Text] [Related]
18. An indirubin derivative, indirubin-3'-monoxime suppresses oral cancer tumorigenesis through the downregulation of survivin.
Lo WY; Chang NW
PLoS One; 2013; 8(8):e70198. PubMed ID: 23967071
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
